From Delay to Damage: Changing the EGPA Trajectory With Early Diagnosis and Biologic Therapy скачать в хорошем качестве

From Delay to Damage: Changing the EGPA Trajectory With Early Diagnosis and Biologic Therapy

Eosinophilic granulomatosis with polyangiitis (EGPA), formerly known as Churg-Strauss syndrome, is a rare autoimmune small-vessel vasculitis that has a complex phenotype with symptomatology that affects multiple organ systems. Join us for this engaging Expert Insights program to learn more about EPGA, an intriguing heterogeneous multisystem disease plagued by delays in diagnosis – and the effective targeted biologic therapies that are now available to treat this disease. Along with a whiteboard animation, multidisciplinary faculty will review the pathophysiologic processes underlying EGPA development, best approaches for prompt diagnosis, and strategies for individualizing therapeutic regimens that improve patient outcomes. You don’t want to miss this informative and thought-provoking session! View the CME Live Stream https://www.exchangecme.com/EGPAChica... Brian D. Jaros, MD Assistant Professor, Medicine (Rheumatology) Feinberg School of Medicine Northwestern University Chicago, Illinois Philip Seo, MD, MHS Associate Professor of Medicine Division of Rheumatology Johns Hopkins University School of Medicine Baltimore, Maryland Michael E. Wechsler, MD, MMSc Professor, Department of Medicine Director, The Cohen Family Asthma Institute Division of Pulmonary, Critical Care and Sleep Medicine Director, Asthma Program National Jewish Health Denver, Colorado #ACR2025 #egpa #respiratorydiseases #allergy #immunology #rheumatology